Albemarle CCO granted 10,867 stock units
Albemarle’s Chief Commercial Officer received a new 10,867-share RSU grant that vests in 2028, raising his reported holdings to 64,310 shares.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
ALBEMARLE CORP (symbol: ALB) is the issuer of record for a Form 4 filing submitted to the SEC. Norris Eric reported acquisition or exercise transactions in this Form 4 filing.
ALBEMARLE CORP (ALB) reported that Chief Commercial Officer Eric Norris received an equity award on September 14, 2026. He was granted 10,867 shares in the form of Restricted Stock Units that vest 100% on March 14, 2028, increasing his directly held position to 64,310 shares. No Rule 10b5-1 trading plan is reported in connection with this award.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock F1 | 10,867 | $0.00 | $0.00 |
Footnotes (1)
- F1. Restricted Stock Units that vest 100% on 03/14/2028, subject to the terms of the award agreement.
Key Figures
Key Terms
Restricted Stock Units financial
vest 100% financial
Rule 10b5-1 regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did ALB (Albemarle) report for Eric Norris?
Did the Albemarle (ALB) Form 4 indicate use of a Rule 10b5-1 trading plan?
Was there any sale of Albemarle (ALB) stock in this Form 4 filing?
AI-generated analysis. How Rhea-AI works. Not financial advice.